We have rendered dozens of opinions involving many diverse technologies in the chemical, material sciences, and electro-mechanical arts. Those opinions range from due diligence evaluations of portfolios of pharmaceutical families targeted for in-licensing, to patentability analyses of medical devices, to infringement by shipping container devices, to freedom-to-operate studies of nanoparticle-filled rubber compositions. Patentability, validity, enforceability, reissue/reexamination, prelitigation, and interference opinions are part of our comprehensive experience. Thrive IP® can provide careful but quick oral opinions and detailed written opinions, depending on the client’s needs and deadlines. In addition, as a neutral third-party, Thrive IP® offers Early Neutral Evaluation (“ENE”) services, assisting parties in defining the issues present in a dispute, the validity of the parties’ positions relative to those particular disputes, and the costs and likely outcomes of litigation and appeal. By exploring risks, costs, and likely outcomes, Thrive IP®’s ENE services can save potential litigants significant litigation costs while ultimately achieving fair and reasonable settlements.